HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief: New Leadership For Lauder Brands; P&G Beauty Head Moves To Fashion; More

This article was originally published in The Rose Sheet

Executive Summary

The Estee Lauder Companies, Procter & Gamble, Avon Products and Markwins announce changes to their executive management ranks, and Liz Earle says she will be leaving the natural-oriented brand she co-founded in 1995.

You may also be interested in...



People In Brief: P&G Names New Head of Beauty; Coty's Macchio Retires; More

There's a new hand steering P&G's beauty business, Coty's looking for a new science chief and Shiseido has done some reorganizing to streamline R&D functions and promote innovation.

Avon's Ongoing Struggles Prompt Renewed Investor Call For CEO Ouster

Management projects a strong second half after Avon's first-quarter sales advanced 2%, reported, but dipped in constant currency. Analysts received the guidance guardedly, and a group of investors led by Barington Capital are unconvinced the firm can turn things around under current leadership.

P&G Enters FY 2017 With Pressure To Execute In Line With Promises

Increased R&D and ad spending, improved consumer communications and other brand-building investments will enable P&G to grow and recapture market share in fiscal 2017, company leadership suggests. While the stage may be set for P&G to “get the belt back,” as one analyst suggests, all are watching for execution.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS109276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel